Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

(2017) Joakim Hertze et al.   JOURNAL OF ALZHEIMERS DISEASE

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

(2013) Per Johansson et al.   PSYCHONEUROENDOCRINOLOGY

Growth hormone (GH) and brain trauma

(2012) Jesús Devesa et al.   HORMONES AND BEHAVIOR

Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease

(2012) Emmanuelle Duron et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

(2012) Konrad Talbot et al.   JOURNAL OF CLINICAL INVESTIGATION

Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice

(2012) Yuki Kita et al.   PSYCHOPHARMACOLOGY

Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2

(2012) Cristina M. Alberini et al.   TRENDS IN NEUROSCIENCES

Insulin resistance and Alzheimer's disease

(2011) Suzanne M. De La Monte   BMB Reports

‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches

(2011) Julien Delrieu et al.   JOURNAL OF NEUROCHEMISTRY

Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats

(2011) Maria Garcia-Fernandez et al.   Journal of Translational Medicine

A critical role for IGF-II in memory consolidation and enhancement

(2011) Dillon Y. Chen et al.   NATURE

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Regulation of Insulin-like Growth Factor-I in Starvation and Injury

(2010) Jean-Paul Thissen et al.   NUTRITION REVIEWS

Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease

(2009) Zivar Salehi et al.   BIOFACTORS

Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice

(2009) Ehud Cohen et al.   CELL

Amyloid β and APP as biomarkers for Alzheimer’s disease

(2009) Henrik Zetterberg et al.   EXPERIMENTAL GERONTOLOGY

Neuronal IGF-1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer’s disease

(2009) Susanna Freude et al.   FASEB JOURNAL

Temporal and Regional Changes in IGF-1/IGF-1R Signaling in the Mouse Brain after Traumatic Brain Injury

(2009) Sindhu Kizhakke Madathil et al.   JOURNAL OF NEUROTRAUMA

Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan

(2009) André Aleman et al.   PROGRESS IN NEUROBIOLOGY

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

(2008) Aileen M. Moloney et al.   NEUROBIOLOGY OF AGING

Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?

(2007) Luigi Puglielli   NEUROBIOLOGY OF AGING